It impairs the bone marrow's ability to produce red blood cells (RBCs), leading to severe anemia and other health ...

Anemia is highly prevalent in patients with chronic heart failure (HF) and is associated with poor clinical outcomes. Multiple mechanisms contribute to anemia in chronic HF, and subnormal ...

Sickle cell anemia requires ongoing, lifelong treatment to improve quality of life and prevent complications. Treatment of sickle cell anemia includes taking measures to treat anemia, prevent ...

Many individuals with sickle cell anemia undergoing controlled ovarian hyperstimulation (COH) with oocyte cryopreser ...

In this review on the treatment of chronic anemia, the causes of chronic anemia that are of major public health importance in developing countries are discussed. These include nutritional ...

Mississauga: GSK has announced that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...

Saeed Sadeghi, MD, explores the future treatment landscape for anemia in lower-risk myelodysplastic syndromes (LR-MDS), ...

LOUISVILLE, Ky. -- More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug ...

The global drug-induced immune hemolytic anemia market, valued at approximately USD 7.8 billion in 2023, is poised for ...

CNW/ - GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...

An expert told CURE that Trodelvy's side effects, such as neutropenia and fatigue, can often be managed through dose ...